Identifying an optimal time window for predicting response to neoadjuvant chemotherapy using breast cancer subtypes and hemoglobin parameters assessed by US-guided optical tomography

  • Quing Zhu
  • , Susan Tannenbaum
  • , Scott H. Kurtzman
  • , Patricia DeFusco
  • , Andrew Ricci
  • , Hamed Vavadi
  • , Feifei Zhou
  • , Chen Xu
  • , Alex Merkulov
  • , Poornima Hegde
  • , Mark Kane
  • , Liqun Wang
  • , Kert Sabbath

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

The study has identified an optimal time window for predicting breast cancer pathological response to neoadjuvant chemotherapy (NAC) based on tumor subtypes, pretreatment total-hemoglobin level and early changes of total-hemoglobin following NAC.

Original languageEnglish
Title of host publicationOptical Tomography and Spectroscopy, OTS 2018
PublisherOptica Publishing Group (formerly OSA)
ISBN (Print)9781943580415
DOIs
StatePublished - 2018
EventOptical Tomography and Spectroscopy, OTS 2018 - Hollywood, United States
Duration: Apr 3 2018Apr 6 2018

Publication series

NameOptics InfoBase Conference Papers
VolumePart F90-OTS 2018
ISSN (Electronic)2162-2701

Conference

ConferenceOptical Tomography and Spectroscopy, OTS 2018
Country/TerritoryUnited States
CityHollywood
Period04/3/1804/6/18

Fingerprint

Dive into the research topics of 'Identifying an optimal time window for predicting response to neoadjuvant chemotherapy using breast cancer subtypes and hemoglobin parameters assessed by US-guided optical tomography'. Together they form a unique fingerprint.

Cite this